Chimeric: Media Thread, page-735

It has been a rough ride since 2022. I have been doing this for a while, and this would be the longest downtrend in biotech I have seen. it can sap confidence, and it can turn some folk away from the market.

But look around. there are many companies that have gone through the duldrums but turn around when they hit the right pivot.

Sometimes, things like HC can help through times like this. That is, if discussion is on pipeline, results vs market cap etc and remains unemotional.

Times like this highlight why you need to be prepared to partially sell and take a profit when things turn around. You cant just buy and hold at this end of the market.

This market cap does not represent the pipeline. So there is lots of potential here. But the knife is still falling.

I hope everyone is doing ok.